Segment Information by Division

For the Period January 1 to December 31

  Download XLS

2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

€ million

 

Silicones

 

Polymers

 

Bio-
solutions

 

Polysilicon

 

Siltronic

 

Other

 

Con-
solidation

 

Group

1

Intangible assets; property, plant and equipment; investment property

2

Investments in joint ventures and associates, financial assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

1,633.8

 

975.3

 

154.1

 

949.4

 

858.5

 

63.8

 

 

4,634.9

Internal sales

 

14.2

 

27.8

 

3.5

 

186.4

 

9.4

 

106.1

 

-347.4

 

Total sales

 

1,648.0

 

1,003.1

 

157.6

 

1,135.8

 

867.9

 

169.9

 

-347.4

 

4,634.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

106.4

 

110.7

 

17.8

 

200.8

 

-92.2

 

-85.4

 

-0.1

 

258.0

Depreciation and impairments/appreciation of noncurrent assets

 

82.9

 

36.7

 

6.7

 

226.7

 

92.9

 

82.9

 

 

528.8

EBITDA

 

189.3

 

147.4

 

24.5

 

427.5

 

0.7

 

-2.5

 

-0.1

 

786.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Result from investments in joint ventures and associates

 

-55.9

 

 

 

 

-26.6

 

 

-0.1

 

-82.6

Impairment losses

 

 

 

 

 

-2.5

 

 

 

-2.5

Additions to property, plant and equipment1

 

70.9

 

58.8

 

19.3

 

698.1

 

73.3

 

56.9

 

 

977.3

Additions to financial assets2

 

87.9

 

 

 

 

29.9

 

0.3

 

 

118.1

Asset additions

 

158.8

 

58.8

 

19.3

 

698.1

 

103.2

 

57.2

 

 

1,095.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,180.4

 

483.2

 

107.6

 

2,417.6

 

1,136.6

 

1,270.5

 

-266.0

 

6,329.9

Liabilities (Dec. 31)

 

569.3

 

220.5

 

44.8

 

1,917.6

 

238.2

 

985.0

 

-263.3

 

3,712.1

Net assets (Dec. 31)

 

611.1

 

262.7

 

62.8

 

500.0

 

898.4

 

285.5

 

-2.7

 

2,617.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in joint ventures and associates included in net assets (Dec. 31)

 

19.3

 

 

 

 

22.2

 

 

-0.5

 

41.0

Research and development expenses

 

31.3

 

13.0

 

6.6

 

12.8

 

67.4

 

48.4

 

-5.0

 

174.5

Employees (Dec. 31)

 

3,960

 

1,365

 

357

 

2,349

 

3,978

 

4,283

 

 

16,292

Employees (average)

 

3,947

 

1,370

 

349

 

2,325

 

4,351

 

4,321

 

 

16,663

  Download XLS

2011

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

€ million

 

Silicones

 

Polymers

 

Bio-
solutions

 

Polysilicon

 

Siltronic

 

Other

 

Con-
solidation

 

Group

1

Intangible assets; property, plant and equipment; investment property

2

Investments in joint ventures and associates, financial assets

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 22.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

1,580.2

 

901.4

 

138.9

 

1,234.8

 

985.1

 

69.3

 

 

4,909.7

Internal sales

 

13.6

 

26.7

 

5.6

 

212.9

 

7.0

 

107.6

 

-373.4

 

Total sales

 

1,593.8

 

928.1

 

144.5

 

1,447.7

 

992.1

 

176.9

 

-373.4

 

4,909.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

103.3

 

76.2

 

13.3

 

545.6

 

-56.7

 

-78.9

 

0.4

 

603.2

Depreciation and impairments/appreciation of noncurrent assets

 

79.6

 

35.6

 

7.1

 

201.7

 

105.9

 

71.1

 

 

501.0

EBITDA

 

182.9

 

111.8

 

20.4

 

747.3

 

49.2

 

-7.8

 

0.4

 

1,104.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Result from investments in joint ventures and associates

 

16.7

 

 

 

 

-24.4

 

 

 

-7.7

Impairment losses

 

 

 

-0.7

 

-25.9

 

-14.8

 

 

 

-41.4

Additions to property, plant and equipment1

 

87.9

 

30.4

 

8.6

 

566.5

 

93.2

 

141.3

 

 

927.9

Additions to financial assets2

 

18.4

 

 

 

 

34.9

 

 

 

53.3

Asset additions

 

106.3

 

30.4

 

8.6

 

566.5

 

128.1

 

141.3

 

 

981.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,197.7

 

478.9

 

96.1

 

1,928.7

 

1,190.4

 

1,672.0

 

-326.8

 

6,237.0

Liabilities (Dec. 31)

 

597.9

 

209.1

 

39.8

 

1,796.4

 

317.3

 

965.5

 

-318.7

 

3,607.3

Net assets (Dec. 31)

 

599.8

 

269.8

 

56.3

 

132.3

 

873.1

 

706.5

 

-8.1

 

2,629.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investments in joint ventures and associates included in net assets (Dec. 31)

 

80.0

 

 

 

 

44.9

 

 

-0.4

 

124.5

Research and development expenses

 

25.4

 

14.1

 

6.2

 

14.5

 

71.7

 

42.8

 

-1.8

 

172.9

Employees (Dec. 31)

 

3,956

 

1,412

 

354

 

2,251

 

4,974

 

4,221

 

 

17,168

Employees (average)

 

3,957

 

1,404

 

357

 

2,054

 

5,002

 

4,160

 

 

16,934